Antigen receptor-engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Immunology Année : 2022

Antigen receptor-engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice

Résumé

CD4+FOXP3+ Tregs are currently explored to develop cell therapies against immune-mediated disorders, with an increasing focus on antigen receptor-engineered Tregs. Deciphering their mode of action is necessary to identify the strengths and limits of this approach. Here, we addressed this issue in an autoimmune disease of the CNS, EAE. Following disease induction, autoreactive Tregs upregulated LAG-3 and CTLA-4 in LNs, while IL-10 and amphiregulin (AREG) were increased in CNS Tregs. Using genetic approaches, we demonstrated that IL-10, CTLA-4, and LAG-3 were nonredundantly required for the protective function of antigen receptor-engineered Tregs against EAE in cell therapy whereas AREG was dispensable. Treg-derived IL-10 and CTLA-4 were both required to suppress acute autoreactive CD4+ T-cell activation, which correlated with disease control. These molecules also affected the accumulation in the recipients of engineered Tregs themselves, underlying complex roles for these molecules. Noteworthy, despite the persistence of the transferred Tregs and their protective effect, autoreactive T cells eventually accumulated in the spleen of treated mice. In conclusion, this study highlights the remarkable power of antigen receptor-engineered Tregs to appropriately provide multiple suppressive factors nonredundantly necessary to prevent autoimmune attacks.

Domaines

Immunologie
Fichier principal
Vignette du fichier
Eur J Immunol - 2022 - Pohar - Antigen receptor‐engineered Tregs inhibit CNS autoimmunity in cell therapy using.pdf (2 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03775805 , version 1 (17-11-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Jelka Pohar, Richard Anthony O'Connor, Benoît Manfroi, Mohamed El-Behi, Luc Jouneau, et al.. Antigen receptor-engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice. European Journal of Immunology, 2022, 52 (8), pp.1335-1349. ⟨10.1002/eji.202249845⟩. ⟨hal-03775805⟩
39 Consultations
98 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More